Skip to main content
HairCited

Association Between Serum Trace Elements Level and Alopecia Areata: A Systematic Review and Meta-Analysis.

Ruiying Wu, Yuanwen Li, Hongye Peng, Zhishan Yang, Ying Wang et al.
Meta-Analysis Journal of cosmetic dermatology 2025 5 sitasi
PubMed DOI CC-BY PDF
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D39739356'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Jenis Studi
Meta-Analysis
Ukuran Sampel
4931
Intervensi
Association Between Serum Trace Elements Level and Alopecia Areata: A Systematic Review and Meta-Analysis. None
Pembanding
Placebo
Arah Efek
Negative
Risiko Bias
Moderate

Abstract

BACKGROUND: Alopecia areata (AA) is a prevalent autoimmune disorder in dermatology, impacting 0.5%-2% of the general population worldwide. More and more scholars are focusing on the important role of micronutrients in the occurrence and development of AA. AIMS: This research aimed to thoroughly and systematically assess the relationship between serum trace element levels and AA. METHODS: The PubMed, Web of Science, EMBASE, and Cochrane Library databases were searched up to May 12, 2024. Two researchers independently screened and identified eligible studies. Depending on the heterogeneity assessed by the I2 statistic, either a random-effects model or a fixed-effects model was used to combine the effect estimates. RESULTS: 34 papers, including 4931 participants from 16 countries, were analyzed. The results of meta-analysis demonstrated patients with AA had a lower serum level of vitamin D (SMD = -0.93 ng/mL, 95% CI = 0.168-0.747, p < 0.05) and serum zinc (SMD = -0.69 μg/dL, 95% CI = -0.99 to -0.39, p < 0.05) than the healthy controls. Vitamin D deficiency was strongly associated to an elevated risk of AA (OR = 2.48, 95% CI = 1.47-4.17, p < 0.05). However, there is no significant difference in serum copper levels between AA patients and the control group. CONCLUSIONS: Our research provided evidence that the levels of serum VD and zinc were associated with the risk of AA. Supplementation with VD and zinc may become a potential treatment for AA.

Full Text

PDF
Loading PDF...

Figures

Tables

TABLE 1

First author, yearResearch settingSample sizeStudy typeAge (case group/health control group)Male/FemaleThe type of trace elementsStudy quality
Sabir Hasanbeyzade, 2024Ankara, Turkey82Case–control study26.85 ± 7/26.88 ± 6.9582/0Vitamin DLow
Ahmed Ibrahim AbdElneam, 2024Shaqra University163Case–control study25 ± 3.9/23.8 ± 2.878/85Vitamin DHigh
Jovan Lalosevic, 2023Serbia64Case–control study5–5737/27Serum zincHigh
Saurabh Swaroop Gupta, 2023Mullana, India50Case–control study10–6034/16Vitamin DLow
Adel Alsenaid, 2023Dawadmi, Shaqra University, and the Department of Dermatology, Qassim University119Cross‐sectional27.1 ± 9.1/27.4 ± 10.3104/15Vitamin DHigh
Yamei Gao, 2022Hefei, China1252Case–control study31.28 ± 14.42/30.89 ± 13.0738/514Vitamin DHigh
Kundak S., 2021Turkey212Case–control study0–18110/102Vitamin DLow
Felix Paolo J. Lizarondo, 2021Philippines58Cross‐sectional19–65/19–6420/38Vitamin DLow
Suchana Marahatta, 2019Nepal60Case–control study28.37 + 10.0731/29Vitamin DLow
Mohamed I., 2019Zagazig, Egypt40Cross‐sectionalVitamin DLow
Harsha Siddappa, 2019India200Case–control study5–60130/70Vitamin DLow
Goknur Ozaydin‐Yavuz, 2019Turkey61Case–control study19–48/20–5435/26Serum copper and zincLow
Venkata Krishna Vamsi Gade, 2018South India90Case–control study32.73 ± 10.43/33.98 ± 8.4828/62Vitamin DHigh
Sara Saniee, 2018Iran198Case–control study27.38 ± 11.94/29.54 ± 13.6598/91Vitamin D/serum zincLow
Mehmet Unal, 2018Turkey64Case–control studyMale:12.4 ± 4.2/16.6 ± 0.8; Female:13.3 ± 4.4/ 16.5 ± 1.0129/25Vitamin DHigh
Manju Daroach, 2018India60Cross‐sectional28.97 ± 9.96/31.17 ± 9.4327/33Vitamin DHigh
Harsha Siddappa, 2018America60Case–control study11.13 ± 4.17/11.47 ± 4.4234/26Vitamin DLow
Yasmeen Jabeen Bhat, 2017India85Cross‐sectional20.96 ± 1.91/21.37 ± 1.70/Vitamin DLow
Seval Erpolat, 2017Turkey73Cross‐sectional20–50/20–5144/29Vitamin DLow
Ruzica Z. Conic, 2017Cleveland Clinic756Case–control study35.54 ± 19.28/35.80 ± 15.56230/526Vitamin DHigh
Rabia Ghafoor, 2017Dermatology OPD, Jinnah Postgraduate Medical Centre, Karachi.60Case–control study15–4524/36Vitamin DLow
Ola Ahmed Bakry, 2016Egypt120Case–control study20–38/19–3664/56Vitamin DLow
Nermeen S. A., 2016Cairo, Egypt100Case–control study7–4478/22Serum zincHigh
Kumpol Aiempanakit, 2016Thailand60Cross‐sectionalMedian age: 37/3820/40Serum zincLow
Nermeen S. A., 2015Cairo, Egypt60Case–control study19–5036/24Vitamin DLow
Mahmud Mahamid, 2014Israel43Case–control study24.2 ± 12.3/27 ± 11.2627/16Vitamin DHigh
Ladan Dastgheib, 2014Iran43Case–control study14–400/43Serum copper and zincHigh
A. Aksu Cerman, 2014Turkey144Cross‐sectional32.21 ± 9.60/32.55 ± 9.7890/54Vitamin DHigh
Soheila Nassiri, 2013Loghman‐e‐Hakim and Shohada‐e‐Tajrish Clinic Dermatology72Case–control study35/37Vitamin DLow
Min Seong Kil, 2013Seoul, Korea126Cross‐sectional36.61 ± 13.81/33.50 ± 10.50Serum zincHigh
Mehdi Amirnia, 2013Dermatology clinic of Tabriz Sina Hospital54Case–control study66.27 ± 9.90/27.11 ± 5.55Serum copper and zincLow
Yasmeen J. Bhat, 2009Departments of Dermatology and Biochemistry, SKIMS Medical College Hospital, Srinagar100Cross‐sectional6–6068/32Vitamin D/serum copper/zincHigh
R. Naginiene, 2004Turkey121Case–control studyVitamin DLow
M. Tasaki, 1993Japan81Case–control studySerum copper and zincHigh

References

  1. Untitled
  2. Untitled
  3. Untitled
  4. Untitled
  5. Untitled
  6. Untitled
  7. Untitled
  8. Untitled
  9. Untitled
  10. Untitled
  11. Untitled
  12. Untitled
  13. Untitled
  14. Untitled
  15. Untitled
  16. Untitled
  17. Untitled
  18. Untitled
  19. Untitled
  20. Untitled
  21. Untitled
  22. Untitled
  23. Untitled
  24. Untitled
  25. Untitled
  26. Untitled
  27. Untitled
  28. Untitled
  29. Untitled
  30. Untitled
  31. Untitled
  32. Untitled
  33. Untitled
  34. Untitled
  35. Untitled
  36. Untitled

Used In Evidence Reviews

Similar Papers